Decline in Psychotic Symptoms in Addition to Cardiac and Metabolic Safety with Cariprazine After Poor Response to Previous Antipsychotic Treatments – A Series of Two Cases

Cariprazine is a highly effective antipsychotic medication of the latest generation. Due to its special receptor profile with D2/D3 partial agonism and high D3 affinity, the use of cariprazine is particularly justified in negative psychotic symptomatic and cardiac prestressed patients or in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Helge H O, Moeller, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055274/
https://www.ncbi.nlm.nih.gov/pubmed/33883898
http://dx.doi.org/10.2147/NDT.S303817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055274/
https://www.ncbi.nlm.nih.gov/pubmed/33883898
http://dx.doi.org/10.2147/NDT.S303817

Ejemplares similares